Does dialysis affect blood glucose levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Dialysis can significantly affect blood glucose levels, and its impact varies depending on the type of dialysis and individual patient factors. According to the most recent study 1, achieving optimal glycemic management in people with diabetes and end-stage kidney disease (ESKD) remains a challenge. During hemodialysis, glucose is removed from the blood as it passes through the dialysis filter, which can cause blood sugar levels to drop, as noted in earlier studies 1. This effect is particularly significant for diabetic patients on dialysis, who may need adjustments to their insulin or other diabetes medications on dialysis days.

Key Considerations

  • The glucose-lowering effect occurs because the dialysis solution typically contains little or no glucose, creating a concentration gradient that pulls glucose from the blood.
  • Patients on dialysis who also have diabetes should monitor their blood sugar levels closely before, during, and after treatments, as they may experience hypoglycemia (low blood sugar).
  • Healthcare providers often recommend reducing insulin doses on dialysis days or having a snack during treatment to prevent dangerous drops in blood sugar.
  • Peritoneal dialysis can affect blood sugar differently, as the dialysis solution used in this method typically contains glucose, which can actually increase blood sugar levels as some is absorbed into the bloodstream, as explained in 1.

Recent Advances

The use of continuous glucose monitoring (CGM) systems and automated insulin delivery (AID) systems, as discussed in 1, has shown promise in managing glucose levels in patients with diabetes and advanced chronic kidney disease, including those on dialysis. These technologies provide valuable insights into an individual’s glucose patterns and allow for more personalized treatment plans, preventing impending and asymptomatic hypoglycemic and/or hyperglycemic episodes. Therefore, the use of such technologies should be considered to improve glycemic control and patient outcomes in this population.

From the Research

Effect of Dialysis on Blood Glucose Levels

  • Dialysis can affect blood glucose levels in patients, particularly those with diabetes 2, 3, 4, 5.
  • The use of dialysate with different glucose concentrations can impact blood glucose levels during dialysis 2, 4.
  • In continuous ambulatory peritoneal dialysis (CAPD) patients, the use of a 4.25% glucose solution can cause plasma glucose levels to rise, while a 1.5% solution has a minimal effect 2.
  • Hemodialysis patients with diabetes may experience a decrease in blood glucose levels during dialysis, with a higher risk of hypoglycemia 4, 5.
  • Peritoneal dialysis patients may have overall increased blood glucose levels compared to hemodialysis patients 3.

Glycemic Control and Dialysis

  • Glycemic control is essential for patients on peritoneal dialysis, and hemoglobin A1c (HbA1c) is commonly used to monitor blood glucose levels 6.
  • However, HbA1c may be underestimated in peritoneal dialysis patients due to various factors affecting hemoglobin and glucose interaction 6.
  • Studies have shown that HbA1c is associated with patient mortality in peritoneal dialysis patients, despite its limitations 6.
  • Regular monitoring of blood glucose levels is crucial for hemodialysis patients with diabetes to prevent hypoglycemia 5.
  • The blood glucose drop percentage can be a sensitive early warning indicator of hypoglycemia in dialysis patients 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Study on the changes of blood glucose in hemodialysis patients with diabetes.

Revista da Associacao Medica Brasileira (1992), 2021

Research

Hemoglobin A1c in patients on peritoneal dialysis: how should we interpret it?

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.